HRS-9813 Capsule

DRUG2 trials

Sponsors

Guangdong Hengrui Pharmaceutical Co., Ltd

Conditions

Pulmonary Fibrosis

Phase 1

A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects

CompletedNCT06939504

Guangdong Hengrui Pharmaceutical Co., LtdPulmonary Fibrosis

Start: 2025-05-04End: 2025-06-23Updated: 2025-07-08

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

RecruitingNCT07229716

Guangdong Hengrui Pharmaceutical Co., LtdPulmonary Fibrosis

Start: 2026-04-04End: 2026-05-01Target: 20Updated: 2026-04-27